Oliver Wyman Actuarial Consulting analyzes what happens after manufacturer costs for brand drugs change hands.
Pharma

Filter By
- Back
- Providers
- Infographics
- Payers
- Digital Health
- Consumerism
- Marketplace Revolution
- Contributor
- Future Market
- Global Health
- Retail Health
- COVID-19
- Health Innovation Journal
- Population Health
- Government Programs
- Health Reform
- OWHIC
- Executive Conversations
- Women in Health
- Practicing Wisely
- Employers
- Summit 2016
- Podcast
- Actuarial